Skip to main content

Table 1 Patient characteristics

From: Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas

Case no. Age (y) /Gender Site INSS N-myc amp. Risk Residual tumor status CTV
(ml)
Prescribed dose [Gy (RBE)]
1 4/F Rt. Retroperitoneum 4 - High Inoperable 147 41.4
2 11/M Upper abdomen Mediastinum 4 - High Recurrence 105 36
3 5/M Upper abdomen Mediastinum 4 - High Complete resection 172 21.6
4 2/F Lt. Adrenal 4 48 High Gross total resection 464 21.6
5 2/F Lt. Adrenal 2A 217 High Subtotal resection 108 36